Oct 31, 2022

Featuring perspectives from Dr Pasi Jänne, including the following topics:

• Introduction: Journal Club with Pasi A Jänne, MD, PhD — Part 1 (0:00)
• Case: An Asian man in his late 60s with adenocarcinoma of the lung and pleural effusion with EGFR amplification (PD-L1 20%) — Jennifer L Dallas, MD (12:33)
• Case: A man...

Oct 28, 2022

Featuring perspectives from Dr Sagar Lonial, including the following topics:

• Journal Club with Sagar Lonial, MD — Part 1 (0:00)
• Case: A man in his late 50s with relapsed t(11;14) multiple myeloma (MM) 17 years after initial induction treatment and ASCT — Rajalaxmi McKenna, MD (16:45)
• Case: A man in his mid 70s with...

Oct 27, 2022

Featuring an interview with Prof Axel Hauschild, including the following topics:

• Pan-tumor approval of dabrafenib/trametinib; data with adjuvant targeted therapy for melanoma (0:00)
• Emerging data with encorafenib/binimetinib for Stage II melanoma; switching from dabrafenib/trametinib...

Oct 27, 2022

Featuring a slide presentation and related discussion from Prof Axel Hauschild, including the following topics:

• Emerging data with targeted agents for metastatic melanoma (0:00)
• Current and future roles for immune checkpoint inhibitors in therapy for melanoma (11:13)
• Comparing targeted agents and immune checkpoint...

Oct 26, 2022

Featuring perspectives from Drs Jeremy Abramson, Sonali Smith and Jason Westin, including the following topics:

• Prologue (0:00)
• First-line treatment (3:38)
• Bispecific antibodies (34:41)
• CAR T-cell therapy (48:21)

CME information and select publications